Code L01XC - des anticorps monoclonaux. ATC (Anatomique Thérapeutique Chimique). Niveau 4

Niveau inférieur

Code L01XC01

édrecolomab

Code L01XC02

rituximab

Code L01XC03

trastuzumab

Code L01XC05

gemtuzumab ozogamicine

Code L01XC06

cetuximab

Code L01XC07

bevacizumab

Code L01XC08

panitumumab

Code L01XC09

catumaxomab

Code L01XC10

ofatumumab

Code L01XC11

ipilimumab

Code L01XC12

brentuximab védotine

Code L01XC13

pertuzumab

Code L01XC14

trastuzumab emtansine

Code L01XC15

obinutuzumab

Code L01XC16

dinutuximab bêta

Code L01XC17

nivolumab

Code L01XC18

pembrolizumab

Code L01XC19

blinatumomab

Code L01XC21

ramucirumab

Code L01XC22

noncytomumab

Code L01XC23

élotuzumab

Code L01XC24

daratumumab

Code L01XC25

mogamulizumab

Code L01XC26

inotuzumab ozogamicine

Code L01XC27

olaratumab

Code L01XC28

durvalumab

Code L01XC29

bermekimab

Code L01XC31

avélumab

Code L01XC32

atézolizumab

Code L01XC33

cémiplimab

Code L01XC34

moxétumomab pasudotox

Code L01XC35

tafasitamab

Code L01XC36

enfortumab védotine

Code L01XC37

polatuzumab védotine

Code L01XC38

isatuximab

Code L01XC39

belantamab mafodotine

Code L01XC40

dostarlimab

Code L01XC41

trastuzumab drukstécan

Niveau supérieur

Code L01X

autres médicaments antinéoplasiques

ATC